With great power

Last week’s midterm elections set the stage for a new Congress and with it, a new set of priorities for healthcare and healthcare oversight. Lawmakers, both new and seasoned alike, will soon face decisions with implications for digital health, including the reauthorization of industry fees that fund FDA drug reviews and questions about the same agency's authority to regulate health AI. In the meantime, federal regulators are making moves of their own.

Transparency is getting renewed attention in some corners of healthcare. The Department of Labor’s recently-released final PBM fee disclosure rule will let self-insured employers audit their PBMs’ fees once a year starting in July 2027. Recent warning letters sent by the FTC signal increased scrutiny of ACA plan marketers that may be misrepresenting limited coverage plans. In health AI, however, HHS is moving in the opposite direction, scrapping transparency requirements and shifting the responsibility to health systems to vet tech developers. As the new Congress gears up to debate health AI, buyers are still being asked to make the calls on what evidence they should demand before putting a tool into patient care. Voters changed who holds power in Washington; how the incoming majority wields that power will help set the terms for digital health in the new year.

Whether exploring new markets, buyer segments, or business models, turning healthcare growth opportunities into a viable business requires the right GTM strategy. Register to join Rock Health on November 10 for a live conversation with leaders from Anchor, Clever Care Health Plan, and City of Hope on what it takes to build—and validate—a winning healthcare GTM strategy.

Headlines

 CMS Postpones Third-Party Remote Patient Monitoring Restriction
Giving practices an extension to move remote monitoring staff in-house Modern Healthcare

CVS To Split Into Two Companies In Stunning Strategic About-Face
Health100 and its 9,000 retail clinics will go with the pharmacy half Healthcare Dive

Lilly To Sell Obesity Drugs Directly On Hims & Hers Site
The compounded GLP-1 pioneer now sells branded drugs at self-pay prices Reuters

Hinge Health Revenue Jumps 52% In Q3 As It Expands Beyond MSK, Eyes Hardware Acquisitions
Migraine clients nearly doubled and GI care launches in 2027 Fierce Healthcare

Athenahealth Launches Tool To Bring Patient Health Records Into Claude
Additional AI assistant connectors to come Fierce Healthcare

Recent Funding

  • nPhase lands $30M to scale its clinical trial data management platform for life sciences
  • Siggy seeds $6M for its clinician-supervised virtual mental health care
  • Family caregiver support platform for Medicare Advantage Avanlee Care inks $3.5M
  • Provider credentialing platform CareLumi collects $2.5M